Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03708055 · ClinicalTrials.gov registry record · NA

Weight Bearing Exercise in Preventing Frailty in Stage I-IIIA Breast Cancer Survivors

A NA study of Overweight and Anatomic Stage II Breast Cancer AJCC v8, sponsored by University of Arizona.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT03708055 is a NA study of Overweight and Anatomic Stage II Breast Cancer AJCC v8 that has completed, run by University of Arizona. The registered enrollment target is 27 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03708055, a NA study of Overweight and Anatomic Stage II Breast Cancer AJCC v8, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well weight bearing exercise works in preventing frailty in stage I-IIIA breast cancer survivors. Weight bearing exercise, including muscle-strengthening, aerobic, flexibility, and balance exercises, can decrease fat and increase muscle, which may lead to reduced frailty.

Interventions

  • BEHAVIORAL Exercise Intervention

Study Locations (1)

Arizona

  • The University of Arizona Medical Center-University Campus - Tucson

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2008-07-24
Est. Completion 2017-04-04
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT03708055

The ClinicalTrials.gov registry entry for NCT03708055 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (98% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Overweight appearing as the primary indexed condition, and to 1 intervention - of which Exercise Intervention is the first listed.

NCT03708055 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT03708055 about?

NCT03708055 is a clinical study titled "Weight Bearing Exercise in Preventing Frailty in Stage I-IIIA Breast Cancer Survivors". This trial studies how well weight bearing exercise works in preventing frailty in stage I-IIIA breast cancer survivors. Weight bearing exercise, including muscle-strengthening, aerobic, flexibility, and balance exercises, can decrease fat and increase muscle, which may lead to reduced frailty.

What is the current status of trial NCT03708055?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2008-07-24. Estimated completion is 2017-04-04.

What conditions does trial NCT03708055 study?

This clinical trial studies the following conditions: Overweight, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8.

What interventions are being tested in trial NCT03708055?

The interventions under investigation include: Exercise Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03708055?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03708055 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.